Status:
COMPLETED
Assessment of the Efficacy of Topical Curcumin in Treatment of Oral Lichen Planus
Lead Sponsor:
Shaymaa Hussein Rafat Kotb
Conditions:
Oral Lichen Planus
Eligibility:
All Genders
20-70 years
Phase:
PHASE3
Brief Summary
to evaluate the therapeutic impact of curcumin as Alternative or Complementary to Triamcinolone Acetonate in Treatment of Oral Lichen Planus.
Detailed Description
Background: Oral lichen planus (OLP) is a chronic inflammatory disorder affecting the mucous membranes, believed to be an immune-mediated condition. Its persisting nature can lead to extended discomfo...
Eligibility Criteria
Inclusion
- clinical diagnosis of OLP
Exclusion
- Any systemic autoimmune disease
- Any current use of anticoagulant or antiplatelet agents (curcumin has inhibitory effects on platelet aggregations).
- Any topical, local or systemic corticosteroids therapy during the past 3 months.
- lichenoid reaction from medications.
- Pregnant or lactation women.
- smokers
Key Trial Info
Start Date :
June 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06605911
Start Date
June 1 2023
End Date
June 1 2024
Last Update
September 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Al-Azhar university
Asyut, Ass, Egypt, 0000